Get the Stockscreener App
1.71
1.72%
-0.03
Edap Tms S A Adr stock is traded at $1.71, with a volume of 24,498.
It is down -1.72% in the last 24 hours and down -2.84% over the past month.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
See More
Previous Close:
$1.74
Open:
$1.6947
24h Volume:
24,498
Relative Volume:
0.18
Market Cap:
$64.31M
Revenue:
$68.72M
Net Income/Loss:
$-24.01M
P/E Ratio:
-2.716
EPS:
-0.6296
Net Cash Flow:
$-24.95M
1W Performance:
-0.58%
1M Performance:
-2.84%
6M Performance:
-30.49%
1Y Performance:
-67.92%
1-Day Range:
$1.63
$1.7548
1-Week Range:
$1.63
$1.8438
52-Week Range:
$1.26
$5.46
Edap Tms S A Adr Stock (EDAP) Company Profile
Compare EDAP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EDAP
Edap Tms S A Adr
|
1.71 | 64.31M | 68.72M | -24.01M | -24.95M | -0.6296 |
|
MCK
Mckesson Corporation
|
724.38 | 88.11B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
293.20 | 55.09B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
164.91 | 36.54B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
70.16 | 8.92B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
7.54 | 623.64M | 10.42B | -38.77M | 323.54M | -0.51 |
Edap Tms S A Adr Stock (EDAP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-04-25 | Downgrade | Jefferies | Buy → Hold |
| Nov-01-22 | Initiated | Jefferies | Buy |
| Apr-28-21 | Initiated | Piper Sandler | Overweight |
| Apr-15-20 | Initiated | B. Riley FBR | Buy |
| Jul-28-14 | Downgrade | Northland Capital | Outperform → Market Perform |
| Jun-16-14 | Initiated | H.C. Wainwright | Buy |
| Mar-05-13 | Initiated | Northland Capital | Outperform |
| Nov-18-10 | Reiterated | Morgan Joseph | Buy |
| Aug-20-09 | Reiterated | Roth Capital | Hold |
| Nov-24-08 | Reiterated | Roth Capital | Hold |
| Mar-26-08 | Reiterated | Roth Capital | Hold |
| Nov-09-07 | Reiterated | Roth Capital | Hold |
| Mar-16-07 | Reiterated | Roth Capital | Hold |
| Jan-24-07 | Reiterated | Roth Capital | Hold |
View All
Edap Tms S A Adr Stock (EDAP) Latest News
EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy - Investing.com
EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy By Investing.com - Investing.com India
edap tms sa announces shareholder meeting for june 2025 By Investing.com - Investing.com India
edap tms sa announces shareholder meeting for june 2025 - Investing.com
H.C. Wainwright cuts EDAP stock price target to $14 By Investing.com - Investing.com South Africa
H.C. Wainwright cuts EDAP stock price target to $14 - Investing.com
EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting - GlobeNewswire Inc.
Focal ablation shows promise in prostate cancer trial - Investing.com
Jefferies cuts EDAP TMS stock rating, slashes target to $2 - Investing.com
Piper Sandler cuts EDAP stock price target to $4.50, keeps rating By Investing.com - Investing.com South Africa
Piper Sandler cuts EDAP stock price target to $4.50, keeps rating - Investing.com India
H.C. Wainwright maintains $19 target on EDAP TMS stock - Investing.com India
Earnings call transcript: EDAP TMS Q4 2024 sees revenue growth, stock surges - Investing.com
Allegro Microsystems Inc (ALGM) Beta Value: Understanding the Market Risk - The News Heater
EDAP TMS SA Sponsored ADR to Host Earnings Call - ACCESS Newswire
Investor Network: EDAP TMS SA Sponsored ADR to Host Earnings Call - ACCESS Newswire
EDAP initiates trial for pancreatic cancer treatment - Investing.com India
Earnings call: EDAP TMS sees growth with Focal One HIFU business - Investing.com
EDAP's Avenda Deal For AI-Assisted Cancer Care Likely To Drive Stock - Barchart.com
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts - Benzinga
Biotech & Pharma News, Stocks, FDA Decision, Clinical Trials - RTTNews
Perkins Capital Raises Exposure in EDAP TMS - Insider Monkey
Friday's Top Biotech and Medical Stocks - 24/7 Wall St.
Edap Tms S A Adr Stock (EDAP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
0.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):